Trial Profile
Phase I, Multiple Oral Dose Study to Evaluate the Tolerability and Pharmacokinetics of Favipiravir in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 12 Oct 2018
Price :
$35
*
At a glance
- Drugs Favipiravir (Primary)
- Indications Ebola virus infections; Influenza virus infections; Viral infections
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Toyama Chemical
- 13 Jun 2016 New trial record